Abstract 4366745: Artificial Intelligence-Derived Myosteatosis on Coronary Artery Calcium CT Scans Predicts Incident COPD: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

M Morteza Naghavi (HeartLung Technologies, Houston, Texas, United States) A Amir Azimi K Kyle Atlas (HeartLung Technologies, Houston, Texas, United States) C Chenyu Zhang A Anthony Reeves (Cornell University, Ithaca , New York, United States) J Jakob Wasserthal (University Basel, Basel, Switzerland) N Nathan Wong C Claudia Henschke (Mount Sinai Hospital, New York, New York, United States) D David Yankelevitz (Mount Sinai Hospital, New York, New York, United States) D David Maron (Stanford University, Stanford, California, United States) R Rozemarijn Vliegenthart M Michael McConnell (Stanford University, Palo Alto, California, United States) J Javier Zulueta (Mount Sinai Hospital, New York, New York, United States) K Kim Williams A Andrea Branch (Mount Sinai Hospital, New York, New York, United States) J Jeffrey mechanick (icahn school of med at mount siani, New York, New York, United States) N Ning Ma R Rowena Yip (Icahn School of Med at Mt Sinai, New York, New York, United States) W Wenjun Fan (State Key Laboratory of Catalysis, Dalian Institute of Chemical Physics) S Sion Roy (UCLA Harbor, Malibu, California, United States) M Matthew Budoff (The Lundquist Institute, Torrance, California, United States) S Sabee Molloi (University of California, Irvine, Irvine, California, United States) I Ioannis Kakadiaris (UNIVERSITY OF HOUSTON, Houston, Texas, United States) P Prediman Shah (Cedars-Sinai Medical Center, Los Angeles, California, United States) G George Abela (MICHIGAN STATE UNIV, East Lansing, Michigan, United States) J Jagat Narula E Emelia Benjamin (Boston University School Medicine, Brookline, Massachusetts, United States) D Daniel Levy (Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.) R Roxana Mehran (Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.M.).) R Robert Kloner (Huntington Medical Research Inst., Pasadena, California, United States)

Abstract

Introduction/Background: Myosteatosis, defined as pathological fat infiltration into skeletal muscle, is an emerging marker of metabolic dysfunction and cardiovascular risk, particularly when measured in abdominal CT. However, its association with lung health and risk of chronic obstructive pulmonary disease (COPD) is not well established. The AI-CVD initiative aims to extract all useful opportunistic screening information from coronary artery calcium scans and combines them with traditional risk factors to create a stronger predictor of cardiovascular diseases. We hypothesized that myosteatosis measured from cardiac CT scans using AI-CVD is associated with increased risk of incident COPD in a population free of clinical cardiovascular disease at baseline. Methods/Approach: A retrospective cohort analysis was conducted using baseline data from Exam 1 of the Multi-Ethnic Study of Atherosclerosis including men and women aged 45 to 84 free of cardiovascular disease at baseline. Myosteatosis was quantified using AI-CVD to segment muscle and compute thoracic skeletal muscle density as a proxy for fat infiltration. Chronic obstructive pulmonary disease (COPD) was defined using clinical diagnosis with ICD codes. Proportional hazards models were used to assess the association between myosteatosis and incident COPD disease over 15 years. Models were adjusted for confounders including age, sex, pack years of smoking, emphysema, body mass index, inflammation, diabetes, and socioeconomic status. Results/Data: A total of 283 cases of incident COPD were identified. Individuals in the lowest quartile of muscle attenuation had significantly higher cumulative incidence compared to other quartiles. In minimally adjusted models, the hazard ratio comparing the lowest to highest quartile was 1.87. In fully adjusted models, the association remained significant with a hazard ratio of 1.32. Conclusion(s): AI-based quantification of myosteatosis on routine cardiac CT scans independently predicts future risk of COPD. Adverse muscle composition in the pectoralis, intercostal, and paraspinal muscles may precede lung function decline. Opportunistic assessment of myosteatosis could enable early identification of individuals at elevated risk and support preventive interventions at elevated risk for COPD and guide preventive strategies before clinical disease onset.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (30)

M

Morteza Naghavi

HeartLung Technologies, Houston, Texas, United States

A

Amir Azimi

K

Kyle Atlas

HeartLung Technologies, Houston, Texas, United States

C

Chenyu Zhang

A

Anthony Reeves

Cornell University, Ithaca , New York, United States

J

Jakob Wasserthal

University Basel, Basel, Switzerland

N

Nathan Wong

C

Claudia Henschke

Mount Sinai Hospital, New York, New York, United States

D

David Yankelevitz

Mount Sinai Hospital, New York, New York, United States

D

David Maron

Stanford University, Stanford, California, United States

R

Rozemarijn Vliegenthart

M

Michael McConnell

Stanford University, Palo Alto, California, United States

J

Javier Zulueta

Mount Sinai Hospital, New York, New York, United States

K

Kim Williams

A

Andrea Branch

Mount Sinai Hospital, New York, New York, United States

J

Jeffrey mechanick

icahn school of med at mount siani, New York, New York, United States

N

Ning Ma

R

Rowena Yip

Icahn School of Med at Mt Sinai, New York, New York, United States

W

Wenjun Fan

State Key Laboratory of Catalysis, Dalian Institute of Chemical Physics

S

Sion Roy

UCLA Harbor, Malibu, California, United States

M

Matthew Budoff

The Lundquist Institute, Torrance, California, United States

S

Sabee Molloi

University of California, Irvine, Irvine, California, United States

I

Ioannis Kakadiaris

UNIVERSITY OF HOUSTON, Houston, Texas, United States

P

Prediman Shah

Cedars-Sinai Medical Center, Los Angeles, California, United States

G

George Abela

MICHIGAN STATE UNIV, East Lansing, Michigan, United States

J

Jagat Narula

E

Emelia Benjamin

Boston University School Medicine, Brookline, Massachusetts, United States

D

Daniel Levy

Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

R

Roxana Mehran

Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (R.M.).

R

Robert Kloner

Huntington Medical Research Inst., Pasadena, California, United States